BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up

5 hours ago

BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while retaining rights to other oncology programs with …

Read Entire Article

BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up

Related

Bitcoin futures demand rises even as BTC sells off: What giv...

Bitmine Boasts World's Largest Ethereum Treasury as Holdings...

Sharps Technology stock soars on $400M Solana treasury plan

H&R Block Enters $350 Million Notes Agreement

Naval Ravikant joins crypto billionaires to boost pro-Trump ...

Medical Device Firm's Stock Spikes After Pivoting to Solana ...

Expert Reveals What Updated XRP ETF Filings Mean In Battle F...

Global regulators, exchanges push back on tokenized stocks i...

Popular

Alien Types: Physicist Reveals 4 Alien Species to Congress! ...

Law of Return: Pedophile Extradition Explained on CBS News s...

How Much Will 1 Bitcoin Will Be Worth In 2030, 2040, & 2050?...

Wall Street Analysts Think This Popular AI Stock Looks Overv...

Bitcoin, Crypto & Markets Poised for Breakout This Week

If you own XRP, BTC, ETH, LINK, Floki & Doge - ACT FAST! The...